Success Metrics

Clinical Success Rate

100.0%

Based on 4 completed trials

Completion Rate

100%(4/4)

Active Trials

1(17%)

Results Posted

75%(3 trials)

Phase Distribution

Ph not_applicable

50%

Ph phase_1

17%

Ph phase_2

17%

Ph phase_3

17%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution6 total trials

Phase 1Safety & dosage

1(16.7%)

Phase 2Efficacy & side effects

1(16.7%)

Phase 3Large-scale testing

1(16.7%)

N/ANon-phased studies

3(50.0%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

100.0%

4 of 4 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Active(1)

Completed(4)

Other(1)

Detailed Status

Completed4

Recruiting1

Suspended1

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

100.0%

Most Advanced

Phase 3

Trials by Phase

Phase 11 (16.7%)

Phase 21 (16.7%)

Phase 31 (16.7%)

N/A3 (50.0%)

Trials by Status

recruiting117%

completed467%

suspended117%

Recent Activity

1 active trials

Showing 5 of 6

recruitingphase_1

Clinical Trials (6)

Showing 6 of 6 trials

NCT05693025Phase 1

Evaluation of the Walk With Ease Program for Fall Prevention

Recruiting

NCT03609502Not Applicable

Perceptual Learning and Memory Consolidation in Adults With and Without LI

Suspended

NCT00158366Not Applicable

Reducing the Weight of Overweight Schizophrenia Patients

Completed

NCT01175382Phase 2

Combined Behavioral and Drug Treatment of Overactive Bladder in Men

Completed

NCT01187498Phase 3

Behavioral Treatment of Overactive Bladder in Men

Completed

NCT00090584Not Applicable

Behavior Enhances Drug Reduction of Incontinence (BE-DRI)

Completed

All 6 trials loaded

Drug Details

Intervention Type: BEHAVIORAL
Total Trials: 6